Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VRML

Vermillion (VRML) Stock Price, News & Analysis

Vermillion logo

About Vermillion Stock (NASDAQ:VRML)

Key Stats

Today's Range
$0.30
$0.31
50-Day Range
$2.54
$4.24
52-Week Range
$0.35
$5.78
Volume
24,099 shs
Average Volume
440,144 shs
Market Capitalization
$29.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.

Receive VRML Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vermillion and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRML Stock News Headlines

Camellia Vermillion
Dr. Richard L. Knutson
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
Vermillion Elementary School
Dr. Kenneth J. Vermillion
Vermillion High School
Sanford Vermillion Medical Center
See More Headlines

VRML Stock Analysis - Frequently Asked Questions

Vermillion, Inc. (NASDAQ:VRML) announced its quarterly earnings results on Thursday, August, 8th. The company reported ($0.06) earnings per share (EPS) for the quarter. The company earned $1.14 million during the quarter. Vermillion had a negative net margin of 307.31% and a negative trailing twelve-month return on equity of 155.25%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vermillion investors own include Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Charter Communications (CHTR), Magnachip Semiconductor (MX) and Cardiff Oncology (TROV).

Company Calendar

Last Earnings
8/08/2019
Today
8/17/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:VRML
CIK
926617
Fax
N/A
Employees
43
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.24 million
Net Margins
-307.31%
Pretax Margin
N/A
Return on Equity
-155.25%
Return on Assets
-103.47%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
2.51
Quick Ratio
2.49

Sales & Book Value

Annual Sales
$4.54 million
Price / Sales
6.43
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
3.33

Miscellaneous

Outstanding Shares
97,378,000
Free Float
N/A
Market Cap
$29.21 million
Optionable
Not Optionable
Beta
3.47
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:VRML) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners